• EU for AZ' COPD maintenance therapy pharmatimes
    December 15, 2020
    AstraZeneca’s Trixeo Aerosphere (formoterol fumarate/glycopyrronium bromide/budesonide) has been approved in the EU for maintenance treatment in adults with moderate to severe chronic obstructive pulmonary disease (COPD).
PharmaSources Customer Service